Navigation Links
Arizona Myeloma Network presents 'Special Award' to TGen president
Date:7/1/2010

PHOENIX, Ariz. July 1, 2010 The Arizona Myeloma Network (AzMN) has presented a "Special Award" to Dr. Jeffrey Trent, President and Research Director of the Translational Genomics Research Institute (TGen).

The award recognizes TGen's help in the 2nd annual Arizona Myeloma Network Race for Hope for All Cancers, a 5K run-walk fundraising event, held April 18 at Westgate City Center in Glendale.

In presenting the award, AzMN President and Founder Barbara Kavanagh also thanked Dr. Trent for TGen's involvement in the 3rd annual Fort Defiance Cancer Awareness and Advocacy Conference, held June 5 at the Navajo Nation Museum in Window Rock, Ariz.

The plaque given to Dr. Trent reads: "We thank you and your researchers for your dedication to cancer patients and families in Arizona. Thank you also for your support of the Arizona Myeloma Network over the past five years."

Dr. Trent and Kavanagh praised the involvement in AzMN events by Dr. Bodour Salhia, a TGen breast cancer researcher who participated in the April 18 run and was one of the original organizers of the first Fort Defiance conference in 2008.

"It's great to have someone like Dr. Bodour Salhia to be able to interact on the patient-advocate side of our work with the Arizona Myeloma Network," said Dr. Trent. "I am very thankful and proud to receive this award from AzMN on behalf of TGen and especially on behalf of our community-involved researchers, like Dr. Salhia."

Kavanagh said Dr. Salhia was especially helpful in participating in the first blood cancer therapies seminar held during the Fort Defiance conference, co-sponsored by the Leukemia & Lymphoma Society, the Mayo Clinic, and the Arizona Cancer Coalition. "We were able to talk for the first time about clinical trials, and that is so important. There is a trust factor now, and the Navajo people themselves are saying they want help and want more information about cancer."

The "All Cancers" race event, Kavanagh added, has been beneficial to the many families who have been hit by multiple types of cancer, "and this event allows Arizonans to raise funds for all of them."

Dr. Salhia said it is extremely important for scientists to get involved with patient-advocacy organizations like AzMN. "For me personally, it makes the science that I do behind the bench very real and human. It is not only a constant reminder of the importance of our research, but for patient advocacy, it is a clear message of hope that can be provided from the scientist to the patient. People are always appreciative of that, and it is extremely fulfilling to be able to touch peoples' lives in that way."


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related medicine news :

1. Americans United for Life Defends Arizonas Informed Consent Law
2. SCAN Health Plan Arizona Named one of Areas Best Places to Work by the Phoenix Business Journal and BestCompaniesAZ, LLC
3. Walking the Talk: SCAN Health Plan Arizona Takes the Lead in Planning the 2010 Walk-the-Fight to Benefit the Muhammad Ali Parkinson Center
4. The Ensign Group Acquires Arizona Skilled Nursing Facility
5. CVS/pharmacy and MinuteClinic Now Providing H1N1 Vaccinations in Arizona
6. Happy New Year for Marty: Arizona Man Drops 164 Pounds on Dr. Siegal's COOKIE DIET and Appears on ABC's Good Morning America
7. Dr. Leonard Kirschner Joins SCAN Health Plan Arizona Board of Directors
8. Is Breast Augmentation Surgery Right for Me? Arizona Breast Surgeon Discusses Various Breast Procedures
9. Smithsonian Institution, Arizona State University announce education and research partnership
10. Arizona State Universitys Decision Theater offers balance to an off-kilter world
11. Apex Heart Care, First Arizona Clinic to Install Shape-HF; New Medical Device Measures Patient Physiology to Define Shortness of Breath
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2017)... Centennial, CO (PRWEB) , ... August 20, 2017 , ... ... in the same household? If so, you may be interested in participating in ... The purpose of this research is to understand more about the relational aspects of ...
(Date:8/19/2017)... York, New York (PRWEB) , ... August 19, ... ... Street Health has announced that it is the first organization with pending recognition ... CDC’s National Diabetes Prevention Program (“DPP”) via group telehealth classes and live video ...
(Date:8/19/2017)... ... August 19, 2017 , ... Physician Partners ... Orlando location as an interventional pain management physician. He brings a wealth of ... of migraine headaches, and significant experience in spinal cord stimulation for chronic pain. ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... specialized asset-light logistics provider of complex transport solutions for mission-critical and non-discretionary ... Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. (NYSE: RRTS). ...
(Date:8/18/2017)... ... ... The Dawn Johnson Insurance Group, a Missouri-based insurance and financial planning firm ... for efforts to educate the local population on cancer realities while attracting donations to ... , Each day in America, roughly 4,600 new cases of cancer are diagnosed and ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... July 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") ... third quarter ended June 30, 2017, and updated its ... For the fiscal third quarter, Hill-Rom ... $0.68 per diluted share in the prior-year period. These ... $0.39 per diluted share primarily related to the non-cash ...
(Date:7/27/2017)... July 27, 2017  West Pharmaceutical Services, Inc. (NYSE: ... for the second-quarter 2017 and updated financial guidance for ... Second-Quarter 2017 Highlights Reported net sales ... the prior-year quarter. Net sales at constant currency (organic) ... EPS was $0.51, compared to $0.60 in the prior-year ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals ... of our clinical trial evaluating Altemia TM , an ... (SCA) and Sickle Cell Disease (SCD). The SCOT Trial, ... the efficacy and safety of Altemia TM in ... conducted under US IND 125274. ...
Breaking Medicine Technology: